BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang J, Zhuang C, Chen J, Chen X, Li X, Zhang T, Wang B, Feng Q, Zheng X, Gong M, Gong Q, Xiao K, Luo K, Li W. Targeted Drug/Gene/Photodynamic Therapy via a Stimuli-Responsive Dendritic-Polymer-Based Nanococktail for Treatment of EGFR-TKI-Resistant Non-Small-Cell Lung Cancer. Adv Mater 2022;:e2201516. [PMID: 35481881 DOI: 10.1002/adma.202201516] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang H, Chen H, Shou D, Quan Y, Cheng J, Chen H, Ning G, Li Y, Xia Y, Zhou Y. Engineering siRNA-loaded and RGDfC-targeted selenium nanoparticles for highly efficient silencing of DCBLD2 gene for colorectal cancer treatment.. [DOI: 10.21203/rs.3.rs-2646308/v1] [Reference Citation Analysis]
2 Zhang J, Tang K, Fang R, Liu J, Liu M, Ma J, Wang H, Ding M, Wang X, Song Y, Yang D. Nanotechnological strategies to increase the oxygen content of the tumor. Front Pharmacol 2023;14. [DOI: 10.3389/fphar.2023.1140362] [Reference Citation Analysis]
3 Yang Y, Cai X, Shi M, Zhang X, Pan Y, Zhang Y, Ju H, Cao P. Biomimetic retractable DNA nanocarrier with sensitive responsivity for efficient drug delivery and enhanced photothermal therapy. J Nanobiotechnology 2023;21:46. [PMID: 36759831 DOI: 10.1186/s12951-023-01806-5] [Reference Citation Analysis]
4 Pan Q, Lu Y, Xie L, Wu D, Liu R, Gao W, Luo K, He B, Pu Y. Recent Advances in Boosting EGFR Tyrosine Kinase Inhibitors-Based Cancer Therapy. Mol Pharm 2023;20:829-52. [PMID: 36588471 DOI: 10.1021/acs.molpharmaceut.2c00792] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tan P, Chen X, Zhang H, Wei Q, Luo K. Artificial intelligence aids in development of nanomedicines for cancer management. Semin Cancer Biol 2023;89:61-75. [PMID: 36682438 DOI: 10.1016/j.semcancer.2023.01.005] [Reference Citation Analysis]
6 Eun Shin H, Wook Oh S, Park W. Hybrid Nanovesicle of Chimeric Antigen Receptor (CAR)-engineered Cell-Derived Vesicle and Drug-Encapsulated Liposome for Effective Cancer Treatment. Journal of Industrial and Engineering Chemistry 2023. [DOI: 10.1016/j.jiec.2023.02.015] [Reference Citation Analysis]
7 Jiang W, Liang M, Lei Q, Li G, Wu S. The Current Status of Photodynamic Therapy in Cancer Treatment. Cancers (Basel) 2023;15. [PMID: 36765543 DOI: 10.3390/cancers15030585] [Reference Citation Analysis]
8 Lu ZG, Shen J, Yang J, Wang JW, Zhao RC, Zhang TL, Guo J, Zhang X. Nucleic acid drug vectors for diagnosis and treatment of brain diseases. Signal Transduct Target Ther 2023;8:39. [PMID: 36650130 DOI: 10.1038/s41392-022-01298-z] [Reference Citation Analysis]
9 Li H, Luo Q, Zhang H, Ma X, Gu Z, Gong Q, Luo K. Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation. Chem Soc Rev 2023;52:47-96. [PMID: 36427082 DOI: 10.1039/d2cs00437b] [Reference Citation Analysis]
10 Shi H, Wan Y, Tian X, Wang L, Shan L, Zhang C, Wu MY, Feng S. Synergistically Enhancing Tumor Chemotherapy Using an Aggregation-Induced Emission Photosensitizer on Covalently Conjugated Molecularly Imprinted Polymer Nanoparticles. ACS Appl Mater Interfaces 2022;14:56585-96. [PMID: 36513426 DOI: 10.1021/acsami.2c17731] [Reference Citation Analysis]
11 Wang H, Qin L, Zhang X, Guan J, Mao S. Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery. J Control Release 2022;352:970-93. [PMID: 36372386 DOI: 10.1016/j.jconrel.2022.10.061] [Reference Citation Analysis]
12 Yan R, Liu J, Dong Z, Peng Q. Nanomaterials-mediated photodynamic therapy and its applications in treating oral diseases. Biomater Adv 2022;144:213218. [PMID: 36436431 DOI: 10.1016/j.bioadv.2022.213218] [Reference Citation Analysis]
13 Tan Y, Cai J, Wang Z. Epsilon-caprolactone-modified polyethylenimine as a genetic vehicle for stem cell-based bispecific antibody and exosome synergistic therapy. Regen Biomater 2023;10:rbac090. [PMID: 36683744 DOI: 10.1093/rb/rbac090] [Reference Citation Analysis]
14 Zhou J, Wang W, Zhang C, Ling Y, Hong X, Su Q, Li W, Mao Z, Cheng B, Tan C, Wu T. Ru(II)-modified TiO2 nanoparticles for hypoxia-adaptive photo-immunotherapy of oral squamous cell carcinoma. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121757] [Reference Citation Analysis]
15 Huang J, Xiao K. Nanoparticles-Based Strategies to Improve the Delivery of Therapeutic Small Interfering RNA in Precision Oncology. Pharmaceutics 2022;14:1586. [DOI: 10.3390/pharmaceutics14081586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]